PAK2 antibody (A01419-2) performs well in ELISA, IF, IHC-P, WB and shows reactivity with Human, Mouse, Rat.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
Filter:
a01419 2 pak2 primary antibodies if testing 6a01419 2 pak2 primary antibodies ihc testing 5a01419 2 pak2 primary antibodies wb testing 1a01419 2 pak2 primary antibodies wb testing 2a01419 2 pak2 primary antibodies wb testing 3a01419 2 pak2 primary antibodies wb testing 4

Anti-PAK2 Antibody

PAK2 antibody

Reactive SpeciesHostApplication
Human, Mouse, RatRabbitELISA, IF, IHC-P, WB

SKU: A01419-2

Size: 0.1 mg

Bundle to save: I do not want free secondary ab
Price:
$481/0.1 mg

In stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Recommend Dilution

Application
Dilution
Species
WB: 0.5-1 μg/mL; IHC: 10 μg/mL; IF: 20 μg/mL.
Antibody validated: Western Blot in human
mouse and rat samples; Immunohistochemistry and Immunofluorescence in mouse samples. All other applications and species not yet tested. Optimal dilutions for each application should be determined by the researcher.

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Product Information

Product Name
Anti-PAK2 Antibody
View all PAK2 Antibodies
Form
Liquid
Uniprot
Gene ID
Storage & Handling
PAK2 antibody can be stored at 4°C, stable for up to one year. Avoid repeated freeze-thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Host
Rabbit
Contents
PAK2 Antibody is supplied in PBS containing ≤0.09% sodium azide.
Clonality
Polyclonal
Isotype
IgG
Immunogen
Anti-PAK2 antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human PAK2. The immunogen is located within amino acids 440-490 of PAK2.
Observed Molecular Weight
68 kDa
Calculated Molecular Weight

58.0 kDa

Background of PAK2
The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity.
Cite This Product
Anti-PAK2 Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # A01419-2)

Review

Have you used Anti-PAK2 Antibody?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-PAK2 Antibody performs excellently in relevant applications for ELISA, IF, IHC-P, WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
A01419-2
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$481.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 3, 2026